facebook
Traded Co logo
Submit
Daily limit: 0/10

10x Science Raises $4.8 Million Seed Round Led By Initialized Capital And Y Combinator

Property Image
SOLD
Andrew Reiter
David Roberts

National

See Similar Deals
the dealplayerscompscontact
Property Image
SOLD

10x Science Raises $4.8 Million Seed Round Led By Initialized Capital And Y Combinator

Andrew Reiter
David Roberts
the dealplayerscompscontact
Contact now

Summary

Transaction Type:Sale

10x Science has raised a $4.8 million seed round led by Initialized Capital, with participation from Y Combinator, Civilization Ventures, and Founder Factor. The transaction addresses a vital aspect of drug discovery by providing AI tools aimed at identifying valuable drug candidates amidst a surge of AI-generated molecules requiring validation.

Summary of transaction details:

  • Deal Type: Seed
  • Transaction Amount: $4,800,000
  • Company: 10x Science
  • Founders: David Roberts & Andrew Reiter
  • Headquarters: San Francisco, California
  • Notable Investors: Initialized Capital, Y Combinator, Civilization Ventures, Founder Factor

Founded in December 2025, 10x Science operates at the intersection of biochemistry and technology, aiming to alleviate challenges in drug discovery through a platform that merges deterministic models with AI to analyze complex mass spectrometry data. This innovative approach helps in expediting protein structure analysis for biologic drug development.

Players

Andrew Reiter
Andrew Reiter
3 deals$2M volume
BUYER
David Roberts
David Roberts
28 deals$417.2M volume
BUYER

Details

SOLD
IMAGE: Science, a startup building AI tools to help biopharma teams determine which drug candidates are actually worth pursuing, has raised a $4.8 million seed round led by Initialized Capital, with participation from Y Combinator, Civilization Ventures, and Founder Factor. Founded in December 2025 by biochemists David Roberts and Andrew Reiter alongside computer scientist and serial founder Vishnu Tejas, the company is tackling a growing bottleneck in drug discovery: the flood of AI-generated molecules that still need to be experimentally validated and characterized. Its platform combines chemistry- and biology-based deterministic models with AI agents to interpret complex mass spectrometry data, aiming to speed up and make sense of protein structure analysis used in biologic drug development. FOUNDERS: David Roberts & Andrew Reiter INVESTORS: Initialized Capital, Y Combinator, Civilization Ventures & Founder Factor ROUND: Seed AMOUNT: $4,800,000 HQ: San Francisco, California

Stay in the Know

Subscribe for insider commercial real estate news, deal highlights, and market insights—delivered straight to your inbox.

By subscribing, you agree to our Terms of Service and Privacy Policy.

Similar Deals

Contact

Get in touch with the broker you want

Suggestions
CRE CalculatorAnalyze deals based on income, expenses, and financing. We automatically filled the calculator with data from the deal you are viewing, fill free to modify it to see how it affects the results.
Deal Type
Operating Income
Operating Expenses (Annual)
Net Operating Income (NOI)

$0.00

Debt Service Coverage Ratio (DSCR)

0.00x

Cap Rate

0.00%

Cash Flow (Annual)$0.00
Cash-on-Cash Return0.00%
Monthly Debt Service$0.00
Annual Debt Service$0.00